About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:6449667
Allelic
Composition
Ifnar1tm1Agt/Ifnar1tm1Agt
Genetic
Background
involves: 129S2/SvPas * BALB/c
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Ifnar1tm1Agt mutation (11 available); any Ifnar1 mutation (60 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• all mice infected with murine hepatitis virus strain 1 (MHV-1) succumb to a sub-lethal dose compared to only about 10% of control BALB/c mice
• mice infected with the mouse-adapted H1N1 influenza A virus, PR8 strain, succumb to a sub-lethal dose compared to only about 20% of control BALB/c mice

immune system
• SARS-CoV-MA15-infected mice show lower levels of CD8 and CD4 T cell apoptos
• SARS-CoV-MA15-infected mice show increased numbers of virus-specific CD4 T cells in lungs
• SARS-CoV-MA15-infected mice show increased numbers of virus-specific CD8 T cells in lungs
• SARS-CoV-MA15-infected mice do show an increase in highly activated inflammatory monocyte-macrophages as is seen in infected BALB/c controls
• SARS-CoV-MA15-infected mice show a decrease in the percentage and numbers of inflammatory monocyte-macrophages that produce the pro-inflammatory cytokines TNF, IL-6, IL1-beta, and iNOS
• SARS-CoV-MA15-infected mice do not show an increase in Ly6ChiCD11b+ cells in the lungs as is seen in controls
• SARS-CoV-MA15- infected mice have reduced levels of cytokines and chemokines in the broncho-alveolar lavage fluid
• all mice infected with murine hepatitis virus strain 1 (MHV-1) succumb to a sub-lethal dose compared to only about 10% of control BALB/c mice
• mice infected with the mouse-adapted H1N1 influenza A virus, PR8 strain, succumb to a sub-lethal dose compared to only about 20% of control BALB/c mice
• mice infected with a lethal dose of the mouse adapted severe acute respiratory syndrome coronavirus (SARS-CoV-MA15) survive the infection, exhibiting only a moderate 15% weight loss and mild to moderate clinical disease
• middle-aged (8-9 month old) mice show increased survival after SARS-CoV-MA15 infection compared to middle-aged BALB/c control mice
• total lung virus loads after SARS-CoV-MA15 infection are the same as in control mice, except for a modest increase at 3 days post infection (dpi) in mutants
• SARS-CoV-MA15 virus is completely cleared from the lungs by 10 dpi
• SARS-CoV-MA15-infected mice show nearly normal lungs at 3 and 5 dpi compared to hyperemia and congestion in controls, with minimal alveolar edema and increased peribronchial-perivascular immune cell infiltration, and reduced lung microvascular leakage

homeostasis/metabolism
• SARS-CoV-MA15- infected mice have reduced levels of cytokines and chemokines in the broncho-alveolar lavage fluid

hematopoietic system
• SARS-CoV-MA15-infected mice show lower levels of CD8 and CD4 T cell apoptos
• SARS-CoV-MA15-infected mice show increased numbers of virus-specific CD4 T cells in lungs
• SARS-CoV-MA15-infected mice show increased numbers of virus-specific CD8 T cells in lungs
• SARS-CoV-MA15-infected mice do show an increase in highly activated inflammatory monocyte-macrophages as is seen in infected BALB/c controls
• SARS-CoV-MA15-infected mice show a decrease in the percentage and numbers of inflammatory monocyte-macrophages that produce the pro-inflammatory cytokines TNF, IL-6, IL1-beta, and iNOS
• SARS-CoV-MA15-infected mice do not show an increase in Ly6ChiCD11b+ cells in the lungs as is seen in controls

cellular
• SARS-CoV-MA15-infected mice show lower levels of CD8 and CD4 T cell apoptos


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory